Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia.
暂无分享,去创建一个
M. Relling | C. Pui | W. Evans | M. Hancock | J. Boyett | M. Hancock | J. Boyett
[1] M. Relling,et al. Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. , 1998, The New England journal of medicine.
[2] R. Weinshilboum,et al. Pharmacokinetics, dose adjustments, and 6‐mercaptopurine/ methotrexate drug interactions in two patients with thiopurine methyltransferase deficiency , 1998, Acta paediatrica.
[3] I. Lewis,et al. Thiopurine methyltransferase deficiency in childhood lymphoblastic leukaemia: 6-mercaptopurine dosage strategies. , 1997, Medical and pediatric oncology.
[4] G. Harrison,et al. Continuing (maintenance) therapy in lymphoblastic leukaemia: lessons from MRC UKALL X , 1997, British journal of haematology.
[5] Ching-Hon Pui,et al. Molecular Diagnosis of Thiopurine S-Methyltransferase Deficiency: Genetic Basis for Azathioprine and Mercaptopurine Intolerance , 1997, Annals of Internal Medicine.
[6] G. Gustafsson,et al. Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] M. Relling,et al. Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia. , 1994, The Journal of clinical investigation.
[8] J. Lilleyman,et al. Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia , 1994, The Lancet.
[9] R. Ragusa,et al. 6-Mercaptopurine cumulative dose: a critical factor of maintenance therapy in average risk childhood acute lymphoblastic leukemia. , 1994, Pediatric hematology and oncology.
[10] C. Pui,et al. Thiopurine methyltransferase activity in American white subjects and black subjects , 1994, Clinical pharmacology and therapeutics.
[11] L. Lennard,et al. High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: quantitation of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample. , 1992, Journal of chromatography.
[12] W. Evans,et al. Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia. , 1991, The Journal of pediatrics.
[13] J. Lilleyman,et al. Importance of 6-mercaptopurine dose in lymphoblastic leukaemia. , 1991, Archives of disease in childhood.
[14] R. Weinshilboum,et al. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia , 1990, The Lancet.
[15] R. Weinshilboum,et al. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. , 1980, American journal of human genetics.
[16] W. J. Spillman. INHERITANCE OF COLOR COAT IN SWINE. , 1906, Science.
[17] J. Lilleyman,et al. 6-Mercaptopurine dose escalation and its effect on drug tolerance in childhood lymphoblastic leukaemia , 1996, Cancer Chemotherapy and Pharmacology.
[18] K. Lucas,et al. Relapse in acute lymphoblastic leukemia as a function of white blood cell and absolute neutrophil counts during maintenance chemotherapy. , 1992, Pediatric hematology and oncology.
[19] K. Schmiegelow. Prognostic significance of methotrexate and 6-mercaptopurine dosage during maintenance chemotherapy for childhood acute lymphoblastic leukemia. , 1991, Pediatric hematology and oncology.
[20] K. Schmiegelow,et al. Maintenance chemotherapy for childhood acute lymphoblastic leukemia: should dosage be guided by white blood cell counts? , 1990, The American journal of pediatric hematology/oncology.
[21] L. Lennard,et al. Assay of 6-thioinosinic acid and 6-thioguanine nucleotides, active metabolites of 6-mercaptopurine, in human red blood cells. , 1987, Journal of chromatography.
[22] D.,et al. Regression Models and Life-Tables , 2022 .